platoseedplatoseed
We engineer proteins that control the operating system of biology.
Epinoma engineers proteins to control biological systems by leveraging epigenetic insights and methylation-preserving amplification technologies. Their focus is on epigenetics to enable disease detection, epi-therapeutics, and accelerated biopharma development.
Epinoma uses EpiAmp, described as the first methyl-preserving amplification technology, to unlock deep insights into the epigenome. The approach aims to preserve methylation signals while amplifying biological material, enabling analysis of epigenetic marks to inform disease detection, patient stratification, and the development of programmable epi-therapeutics that modulate epigenetic states without changing genomic sequences.
Who it’s for: Biotech and pharma researchers, biopharma companies, diagnostic developers, and researchers focusing on epigenetics and disease stratification.
Hiring/traction mentions not explicit; mentions partnerships and contact options, and ongoing research in epigenetics and biopharma acceleration.
Background in translational medicine with previous biotech and medtech development experience. Passionate about developing technologies that will change patients' lives.
Background in chemistry and biomedical science. In depth experience in developing novel methods for diagnosis and prognosis. Passionate about improving patient outcome with innovative sciences and technologies.
Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
Medicinal Chemistry powered by Machine Learning
